Martin Hennenberg

2.8k total citations
110 papers, 2.2k citations indexed

About

Martin Hennenberg is a scholar working on Urology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Martin Hennenberg has authored 110 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Urology, 50 papers in Endocrinology, Diabetes and Metabolism and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Martin Hennenberg's work include Urinary Bladder and Prostate Research (56 papers), Hormonal and reproductive studies (42 papers) and Prostate Cancer Diagnosis and Treatment (17 papers). Martin Hennenberg is often cited by papers focused on Urinary Bladder and Prostate Research (56 papers), Hormonal and reproductive studies (42 papers) and Prostate Cancer Diagnosis and Treatment (17 papers). Martin Hennenberg collaborates with scholars based in Germany, United States and China. Martin Hennenberg's co-authors include Tilman Sauerbruch, Jonel Trebicka, Christian G. Stief, Jörg Heller, Christian Gratzke, Frank Strittmatter, Erwin Biecker, Michael Schepke, Beata Rutz and Raphaela Waidelich and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Martin Hennenberg

104 papers receiving 2.2k citations

Peers

Martin Hennenberg
Sabine Klein Germany
Hongbo Cai United States
Gene LeSage United States
Kang Yang China
Martin Hennenberg
Citations per year, relative to Martin Hennenberg Martin Hennenberg (= 1×) peers Paola Maroni

Countries citing papers authored by Martin Hennenberg

Since Specialization
Citations

This map shows the geographic impact of Martin Hennenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Hennenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Hennenberg more than expected).

Fields of papers citing papers by Martin Hennenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Hennenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Hennenberg. The network helps show where Martin Hennenberg may publish in the future.

Co-authorship network of co-authors of Martin Hennenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Hennenberg. A scholar is included among the top collaborators of Martin Hennenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Hennenberg. Martin Hennenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Michel, Martin C., et al.. (2025). β3‐Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation. Neurourology and Urodynamics. 44(7). 1498–1502.
3.
Ciotkowska, Anna, Beata Rutz, Heiko Schulz, et al.. (2024). Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions. Biomedicine & Pharmacotherapy. 177. 117066–117066. 1 indexed citations
4.
Tamalunas, Alexander, Alexander Büchner, Thomas Kolben, et al.. (2024). Phytomedicines in Pharmacotherapy of LUTS/BPH – What Do Patients Think?. Patient Preference and Adherence. Volume 18. 2507–2518. 1 indexed citations
5.
Sauerbruch, Tilman, Martin Hennenberg, Jonel Trebicka, & Robert Schierwagen. (2023). Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?. Frontiers in Medicine. 9. 1100966–1100966. 8 indexed citations
7.
8.
Yu, Qingfeng, Yeda Chen, Bingsheng Li, et al.. (2021). Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle. Acta Pharmaceutica Sinica B. 11(7). 1914–1930. 13 indexed citations
9.
Schneider, Stephanie, Oliver T. Keppler, Bingsheng Li, et al.. (2021). ADP Ribosylation Factor 6 Promotes Contraction and Proliferation, Suppresses Apoptosis and Is Specifically Inhibited by NAV2729 in Prostate Stromal Cells. Molecular Pharmacology. 100(4). 356–371. 11 indexed citations
10.
Tamalunas, Alexander, et al.. (2020). Inhibition of human prostate smooth muscle contraction by thalidomide: A novel remedy in LUTS?. European Urology Open Science. 19. e989–e990. 1 indexed citations
11.
Wang, Xiaolong, Bingsheng Li, Anna Ciotkowska, et al.. (2020). Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α1-blockers. European Journal of Pharmacology. 873. 172985–172985. 18 indexed citations
12.
Kammerer, Robert, Lukas Rüttiger, Rainer Riesenberg, et al.. (2012). Loss of Mammal-specific Tectorial Membrane Component Carcinoembryonic Antigen Cell Adhesion Molecule 16 (CEACAM16) Leads to Hearing Impairment at Low and High Frequencies. Journal of Biological Chemistry. 287(26). 21584–21598. 38 indexed citations
13.
Bauer, Ricarda M., Frank Strittmatter, Christian Gratzke, et al.. (2011). Coupling of α<sub>1</sub>-Adrenoceptors to ERK1/2 in the Human Prostate. Urologia Internationalis. 86(4). 427–433. 14 indexed citations
14.
Hennenberg, Martin, Boris Schlenker, Alexander Roosen, et al.. (2011). Beta-arrestin-2 is expressed in human prostate smooth muscle and a binding partner of α1A-adrenoceptors. World Journal of Urology. 29(2). 157–163. 13 indexed citations
16.
Hennenberg, Martin, et al.. (2009). Vascular hyporesponsiveness to angiotensin II in rats with CCl4‐induced liver cirrhosis. European Journal of Clinical Investigation. 39(10). 906–913. 31 indexed citations
17.
Trebicka, Jonel, Martin Hennenberg, Frank Lammert, et al.. (2008). Beta-3-adrenoceptors: a putative therapeutic target in liver cirrhosis of humans and animals. Hepatology. 48(4). 1 indexed citations
18.
Biecker, Erwin, Jonel Trebicka, Alice Y. Kang, et al.. (2008). Treatment of bile duct‐ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension. Liver International. 28(3). 331–338. 28 indexed citations
19.
Trebicka, Jonel, Martin Hennenberg, Wim Laleman, et al.. (2007). Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. Hepatology. 46(1). 242–253. 229 indexed citations
20.
Trebicka, Jonel, Wim Laleman, Martin Hennenberg, et al.. (2006). Atorvastatin induces expression of eNOS and activation of NO-signaling in cirrhotic livers and hepatic stellate cells. Hepatology. 44(4).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026